Hanfords US Vet Go-Dry Dry Cow Mastitis Treatment

Details ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.  ToMORROW has been an effective prolonged therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.1,2 ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by  Streptococcus agalactiae  and  Staphylococcus aureus  including penicillin-resistant strains. ToMORROW is formulated with cephapirin benzathine to provide broad spectrum and long-acting therapy that dry cows need. Features & Benefits TOP REASONS TO USE ToMORROW® (cephapirin benzathine) Shorter milk withhold.72 hours after calving versus 96 hours for QUARTERMASTER means you can put your cows back into production sooner after calving.  Shorter slaughter withhold.42 days after last infusion with ToMORROW treatment compared to 60 days for QUARTERMASTER allows you to move 18 days faster.  Targets the bacteria most common at dry-off.ToMORROW treatment effectively controls Gram-positive organisms, which represent 94% of infections that occur during dry-off.1  Less expensive, equally effective.Producers and vets can save an average of 35% per cow when treating with ToMORROW vs. SPECTRAMAST DC.3  Increases convenience and reduces the risk of new infections.The Opti-Sert® tip reduces new mastitis infections by up to 50%4 and makes partial insertion much easier. Dosage & Administration Presentations Pail containing 144 x 10-mL syringes and 144 convenient single-use alcohol pads. Cartons containing 12 x 10-mL syringes with 12 convenient single-use alcohol pads.  Partial insertion reduces new infections With the Opti-Sert® applicator tip, partial insertion reduces the incidence of new infections during the dry period.4 Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent.4  Dosage Information Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.